These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9163695)

  • 1. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice.
    Steffensen IL; Paulsen JE; Eide TJ; Alexander J
    Carcinogenesis; 1997 May; 18(5):1049-54. PubMed ID: 9163695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele.
    Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J
    Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: perinatal susceptibility, regional variation, and correlation with DNA adducts.
    Steffensen IL; Schut HA; Paulsen JE; Andreassen A; Alexander J
    Cancer Res; 2001 Dec; 61(24):8689-96. PubMed ID: 11751386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice.
    Møllersen L; Vikse R; Andreassen A; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J
    Mutat Res; 2004 Jan; 557(1):29-40. PubMed ID: 14706516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age at exposure and Apc status influence the levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in mouse intestine and liver.
    Steffensen IL; Schut HA; Alexander J
    Mutat Res; 2005 Nov; 587(1-2):73-89. PubMed ID: 16202642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice.
    Paulsen JE; Steffensen IL; Andreassen A; Vikse R; Alexander J
    Carcinogenesis; 1999 Jul; 20(7):1277-82. PubMed ID: 10383901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of genetic background on spontaneous or 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumorigenesis in Min/+ mice.
    Steffensen IL; Alexander J
    Cancer Lett; 2006 Aug; 240(2):289-96. PubMed ID: 16343741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The food mutagen 2-amino-9H-pyrido[2,3-b]indole (AalphaC) but not its methylated form (MeAalphaC) increases intestinal tumorigenesis in neonatally exposed multiple intestinal neoplasia mice.
    Steffensen IL; Paulsen JE; Alexander J
    Carcinogenesis; 2002 Aug; 23(8):1373-8. PubMed ID: 12151357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine.
    Tsukamoto T; Kozaki K; Nishikawa Y; Yamamoto M; Fukami H; Inoue M; Wakabayashi K; Tatematsu M
    Jpn J Cancer Res; 1999 Jul; 90(7):720-5. PubMed ID: 10470283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL; Schut HA; Nesland JM; Tanaka K; Alexander J
    Mutat Res; 2006 Dec; 611(1-2):71-82. PubMed ID: 16962818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility.
    Ishiguro Y; Ochiai M; Sugimura T; Nagao M; Nakagama H
    Carcinogenesis; 1999 Jun; 20(6):1063-8. PubMed ID: 10357789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Ushigome M; Fujiwara K; Ubagai T; Kawamori T; Sugimura T; Nagao M; Nakagama H
    Am J Pathol; 2003 Oct; 163(4):1607-14. PubMed ID: 14507667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term carcinogenicity testing of a potent murine intestinal mutagen, 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhIP), in Apc1638N transgenic mice.
    Sørensen IK; Kristiansen E; Mortensen A; van Kranen H; van Kreijl C; Fodde R; Thorgeirsson SS
    Carcinogenesis; 1997 Apr; 18(4):777-81. PubMed ID: 9111214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice.
    Collett GP; Robson CN; Mathers JC; Campbell FC
    Carcinogenesis; 2001 May; 22(5):821-5. PubMed ID: 11323404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene.
    Andreassen A; Møllersen L; Vikse R; Steffensen IL; Mikalsen A; Paulsen JE; Alexander J
    Mutat Res; 2002 May; 517(1-2):157-66. PubMed ID: 12034317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High potency of bioactivation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mouse colon epithelial cells with Apc(Min) mutation.
    Bellocq D; Molina J; Rathahao E; Canlet C; Taché S; Martin PG; Pierre F; Paris A
    Mutat Res; 2008 May; 653(1-2):34-43. PubMed ID: 18434241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Ochiai M; Imai H; Sugimura T; Nagao M; Nakagama H
    Jpn J Cancer Res; 2002 May; 93(5):478-83. PubMed ID: 12036442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
    Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
    Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More frequent beta-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-treated rats.
    Tsukamoto T; Tanaka H; Fukami H; Inoue M; Takahashi M; Wakabayashi K; Tatematsu M
    Jpn J Cancer Res; 2000 Aug; 91(8):792-6. PubMed ID: 10965019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.